| EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts: Subcommittee on Antifungal Susceptibility … JL Rodriguez-Tudela, MC Arendrup, F Barchiesi, J Bille, E Chryssanthou, ... Clinical Microbiology and Infection 14 (4), 398-405, 2008 | 798* | 2008 |
| Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus JWM Van der Linden, MC Arendrup, A Warris, K Lagrou, H Pelloux, ... Emerging infectious diseases 21 (6), 1041, 2015 | 380 | 2015 |
| High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease DW Denning, S Park, C Lass-Florl, MG Fraczek, M Kirwan, R Gore, ... Clinical infectious diseases 52 (9), 1123-1129, 2011 | 361 | 2011 |
| Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009 A Bueid, SJ Howard, CB Moore, MD Richardson, E Harrison, P Bowyer, ... Journal of Antimicrobial Chemotherapy 65 (10), 2116-2118, 2010 | 361 | 2010 |
| The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus MG Fraczek, M Bromley, A Buied, CB Moore, R Rajendran, R Rautemaa, ... Journal of Antimicrobial Chemotherapy 68 (7), 1486-1496, 2013 | 280 | 2013 |
| Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts JL Rodriguez-Tudela, F Barchiesi, J Bille, E Chryssanthou, ... Clinical microbiology and infection 9 (8), i-viii, 2003 | 244 | 2003 |
| Multi-azole resistance in Aspergillus fumigatus SJ Howard, I Webster, CB Moore, RE Gardiner, S Park, DS Perlin, ... International journal of antimicrobial agents 28 (5), 450-453, 2006 | 240 | 2006 |
| Interlaboratory variability of caspofungin MICs for Candida spp. using CLSI and EUCAST methods: should the clinical laboratory be testing this agent? A Espinel-Ingroff, MC Arendrup, MA Pfaller, LX Bonfietti, B Bustamante, ... Antimicrobial agents and chemotherapy 57 (12), 5836-5842, 2013 | 232 | 2013 |
| Adverse reactions to voriconazole AE Boyd, S Modi, SJ Howard, CB Moore, BG Keevil, DW Denning Clinical infectious diseases 39 (8), 1241-1244, 2004 | 232 | 2004 |
| Pregnancy-related changes in the maternal gut microbiota are dependent upon the mother's periconceptional diet W Gohir, FJ Whelan, MG Surette, C Moore, JD Schertzer, DM Sloboda Gut microbes 6 (5), 310-320, 2015 | 212 | 2015 |
| Antifungal drug resistance in Aspergillus CB Moore, N Sayers, J Mosquera, J Slaven, DW Denning Journal of Infection 41 (3), 203-220, 2000 | 209 | 2000 |
| High prevalence of antifungal resistance in Candida spp. from patients with AIDS D Law, CB Moore, HM Wardle, LA Ganguli, MGL Keaney, DW Denning Journal of Antimicrobial Chemotherapy 34 (5), 659-668, 1994 | 199 | 1994 |
| Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing … M Cuenca-Estrella, CB Moore, F Barchiesi, J Bille, E Chryssanthou, ... Clinical microbiology and infection 9 (6), 467-474, 2003 | 159 | 2003 |
| Efficacy and safety of posaconazole for chronic pulmonary aspergillosis TW Felton, C Baxter, CB Moore, SA Roberts, WW Hope, DW Denning Clinical infectious diseases 51 (12), 1383-1391, 2010 | 151 | 2010 |
| Toxicodynamics of itraconazole: implications for therapeutic drug monitoring JM Lestner, SA Roberts, CB Moore, SJ Howard, DW Denning, WW Hope Clinical infectious diseases 49 (6), 928-930, 2009 | 142 | 2009 |
| In vitro activity of SCH-56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp KL Oakley, CB Moore, DW Denning Antimicrobial agents and chemotherapy 41 (5), 1124-1126, 1997 | 134 | 1997 |
| A systematic review of fluconazole resistance in clinical isolates of Cryptococcus species F Bongomin, RO Oladele, S Gago, CB Moore, MD Richardson Mycoses 61 (5), 290-297, 2018 | 127 | 2018 |
| Lack of correlation of in vitro amphotericin B susceptibility testing with outcome in a murine model of Aspergillus infection EM Johnson, KL Oakley, SA Radford, CB Moore, P Warn, DW Warnock, ... Journal of Antimicrobial Chemotherapy 45 (1), 85-93, 2000 | 122 | 2000 |
| In Vitro Activity of the Echinocandin Antifungal Agent LY303,366 in Comparison with Itraconazole and Amphotericin B against Aspergillus spp KL Oakley, CB Moore, DW Denning Antimicrobial agents and chemotherapy 42 (10), 2726-2730, 1998 | 112 | 1998 |
| Be healthy in pregnancy: exploring factors that impact pregnant women's nutrition and exercise behaviours LN Grenier, SA Atkinson, MF Mottola, O Wahoush, L Thabane, F Xie, ... Maternal & child nutrition 17 (1), e13068, 2021 | 106 | 2021 |
